Henrik Sune Andersen

2.0k total citations · 1 hit paper
22 papers, 1.6k citations indexed

About

Henrik Sune Andersen is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Henrik Sune Andersen has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Immunology and 3 papers in Organic Chemistry. Recurrent topics in Henrik Sune Andersen's work include Protein Tyrosine Phosphatases (14 papers), Galectins and Cancer Biology (13 papers) and RNA modifications and cancer (4 papers). Henrik Sune Andersen is often cited by papers focused on Protein Tyrosine Phosphatases (14 papers), Galectins and Cancer Biology (13 papers) and RNA modifications and cancer (4 papers). Henrik Sune Andersen collaborates with scholars based in Denmark, Sweden and United States. Henrik Sune Andersen's co-authors include Niels Peter Hundahl Møller, Lars Iversen, Günther H. Peters, Ole H. Olsen, Paul G. Drake, Sven Branner, Nicholas K. Tonks, Jannik N. Andersen, Peter Gildsig Jansen and Karin Möller and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Henrik Sune Andersen

21 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains

2001 581 citations Jannik N. Andersen, Ole Hartvig Mortensen et al. Molecular and Cellular Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henrik Sune Andersen Denmark	16	1.4k	795	194	188	170	22	1.6k
Sven Branner Denmark	17	1.0k 0.8×	404 0.5×	513 2.6×	132 0.7×	143 0.8×	27	1.5k
George F. Allan United States	22	957 0.7×	240 0.3×	171 0.9×	120 0.6×	431 2.5×	46	2.0k
Jinlei Bian China	26	1.1k 0.8×	168 0.2×	392 2.0×	199 1.1×	441 2.6×	98	1.9k
Kathryn Skorey Canada	17	597 0.4×	300 0.4×	123 0.6×	97 0.5×	193 1.1×	29	892
Tingfang Yi United States	17	1.0k 0.7×	141 0.2×	281 1.4×	205 1.1×	100 0.6×	25	1.7k
Edward H. Walker United Kingdom	9	1.8k 1.3×	174 0.2×	300 1.5×	34 0.2×	223 1.3×	11	2.2k
Jin-Zhang Zeng China	22	708 0.5×	205 0.3×	105 0.5×	43 0.2×	136 0.8×	49	1.1k
Rubén D. Garcia-Ordoñez United States	16	580 0.4×	256 0.3×	169 0.9×	22 0.1×	80 0.5×	25	1.2k
Huiping Zhao United States	26	968 0.7×	115 0.1×	175 0.9×	86 0.5×	277 1.6×	58	1.6k
Xuewei Wu China	15	693 0.5×	111 0.1×	212 1.1×	74 0.4×	463 2.7×	28	1.3k

Countries citing papers authored by Henrik Sune Andersen

Since Specialization

Citations

This map shows the geographic impact of Henrik Sune Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Sune Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Sune Andersen more than expected).

Fields of papers citing papers by Henrik Sune Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Sune Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Sune Andersen. The network helps show where Henrik Sune Andersen may publish in the future.

Co-authorship network of co-authors of Henrik Sune Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Sune Andersen. A scholar is included among the top collaborators of Henrik Sune Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Sune Andersen. Henrik Sune Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thygesen, Peter, Henrik Sune Andersen, Carsten Behrens, et al.. (2017). Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone. Growth Hormone & IGF Research. 35. 8–16. 26 indexed citations

Matthiesen, Finn, et al.. (2014). A thiol functionalized cryogel as a solid phase for selective reduction of a cysteine residue in a recombinant human growth hormone variant. Journal of Biotechnology. 173. 76–85. 8 indexed citations

Lund, Ida Katrine, et al.. (2005). Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. Journal of Molecular Endocrinology. 34(2). 339–351. 102 indexed citations

Lund, Ida Katrine, Henrik Sune Andersen, Lars Iversen, et al.. (2004). Structure-based Design of Selective and Potent Inhibitors of Protein-tyrosine Phosphatase β. Journal of Biological Chemistry. 279(23). 24226–24235. 28 indexed citations

Möller, Karin, Günther H. Peters, Henrik Sune Andersen, et al.. (2004). Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis. Biochemical Journal. 378(2). 421–433. 28 indexed citations

Frimurer, Thomas M., Günther H. Peters, Lars Iversen, et al.. (2003). Ligand-Induced Conformational Changes: Improved Predictions of Ligand Binding Conformations and Affinities. Biophysical Journal. 84(4). 2273–2281. 71 indexed citations

Høy, Marianne, Hervør L. Olsen, Henrik Sune Andersen, et al.. (2003). Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca2+-dependent exocytosis in pancreatic α- and β-cells. European Journal of Pharmacology. 466(1-2). 213–221. 16 indexed citations

Holsworth, Daniel D., Roy T. Uyeda, Yu Ge, et al.. (2003). A Facile Synthesis of Racemic 2-Aminomethyl-4-oxo-piperidine Intermediates. Synthetic Communications. 33(10). 1789–1795.

Drake, Paul G., Günther H. Peters, Henrik Sune Andersen, Wiljan Hendriks, & Niels Peter Hundahl Møller. (2003). A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta). Biochemical Journal. 373(2). 393–401. 17 indexed citations

10.

Iversen, Lars, Karin Möller, Günther H. Peters, et al.. (2002). Structure Determination of T Cell Protein-tyrosine Phosphatase. Journal of Biological Chemistry. 277(22). 19982–19990. 151 indexed citations

11.

Lau, Jesper, Thomas Kruse Hansen, John Paul Kilburn, et al.. (2002). A convenient large-scale chiral synthesis of protected 2-substituted 4-oxo-piperidine derivatives. Tetrahedron. 58(36). 7339–7344. 8 indexed citations

12.

Andersen, Henrik Sune, Ole H. Olsen, Lars Iversen, et al.. (2002). Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B. Journal of Medicinal Chemistry. 45(20). 4443–4459. 110 indexed citations

13.

Iversen, Lars, Henrik Sune Andersen, Karin Möller, et al.. (2001). Steric Hindrance as a Basis for Structure-Based Design of Selective Inhibitors of Protein-Tyrosine Phosphatases. Biochemistry. 40(49). 14812–14820. 59 indexed citations

14.

Breinholt, Jens, Claus Jeppesen, Sven Branner, et al.. (2001). Synthesis of 2‐amino‐4h‐thiazolo[5,4‐b]indole and characterization of its colored conversion products with protein tyrosine phosphatase inhibitory activity. Journal of Heterocyclic Chemistry. 38(3). 569–577. 7 indexed citations

15.

Andersen, Jannik N., Ole Hartvig Mortensen, Günther H. Peters, et al.. (2001). Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains. Molecular and Cellular Biology. 21(21). 7117–7136. 581 indexed citations breakdown →

16.

Andersen, Henrik Sune, Lars Iversen, Claus Jeppesen, et al.. (2000). 2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine Phosphatases. Journal of Biological Chemistry. 275(10). 7101–7108. 105 indexed citations

17.

Peters, Günther H., Lars Iversen, Sven Branner, et al.. (2000). Residue 259 Is a Key Determinant of Substrate Specificity of Protein-tyrosine Phosphatases 1B and α. Journal of Biological Chemistry. 275(24). 18201–18209. 42 indexed citations

18.

Iversen, Lars, Henrik Sune Andersen, Sven Branner, et al.. (2000). Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B. Journal of Biological Chemistry. 275(14). 10300–10307. 150 indexed citations

19.

Westergaard, Niels, Christian L. Brand, Rikke Lewinsky, et al.. (1999). Peroxyvanadium Compounds Inhibit Glucose-6-phosphatase Activity and Glucagon-Stimulated Hepatic Glucose Output in the Ratin Vivo. Archives of Biochemistry and Biophysics. 366(1). 55–60. 21 indexed citations

20.

Ankersen, Michael, et al.. (1998). Discovery of a Novel Non-Peptide Somatostatin Agonist with SST₄ Selectivity. Journal of the American Chemical Society. 120(7). 1368–1373. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact